Global Statistics

All countries
548,935,393
Confirmed
Updated on June 26, 2022 8:18 pm
All countries
520,730,887
Recovered
Updated on June 26, 2022 8:18 pm
All countries
6,350,765
Deaths
Updated on June 26, 2022 8:18 pm
Sunday, July 3, 2022

Global Statistics

All countries
548,935,393
Confirmed
Updated on June 26, 2022 8:18 pm
All countries
520,730,887
Recovered
Updated on June 26, 2022 8:18 pm
All countries
6,350,765
Deaths
Updated on June 26, 2022 8:18 pm
Molderizer and Safe Shield

BA.5 Omicron Subvariant Spreading Quickly, Could Become Dominant Strain of COVID in U.S.: CDC – NBC Chicago

Global coronavirus cases cross 544.91 mln

WASHINGTON - The global COVID-19 case tally reached over 544.91 million with 6,746,636 deaths recorded to date, according to a Reuters tally on Saturday.The...

RPI gets $3.5M to develop COVID-19 antiviral drug

TROY, N.Y. (NEWS10) — Rensselaer Polytechnic Institute researchers have secured a five-year, $3.5 million grant to develop a low-dose, oral COVID antiviral drug that can be administered...

Japan’s secret to taming the coronavirus: peer pressure

To understand how Japan has fared better than most of the world in containing the dire consequences of the coronavirus pandemic, consider Mika...


According to the latest estimates from the Centers for Disease Control and Prevention, an omicron subvariant that has been the dominant strain of COVID-19 in the U.S. for more than a month is beginning to lose steam, and yet another variant of omicron is quickly gaining momentum.

Those estimates indicate that the BA.2.12.1 lineage of omicron continues to be the dominant strain of COVID-19 in the United States, and is responsible for an estimated 56% of cases.

That number continues to decline however as another strain, the BA.5 subvariant, continues to gain momentum, making up an estimated 23.5% of cases in the last week.

Those increases paint a troubling picture, as recent studies have suggested that previous coronavirus infections and COVID-19 vaccinations are less effective at preventing infection against the BA.4 and BA.5 omicron subvariants.

According to the New England Journal of Medicine, studies have shown that “the levels of neutralizing antibodies” that previous infection or vaccinations create in the body are less effective against the BA.4 and BA.5 subvariants, but still provide “substantial protection” against severe illness.

The research could indicate that BA.4 and BA.5 could cause increased infections among all populations, including those who have been vaccinated and boosted, but also indicates that those vaccinations will still help to guard against severe illness.

According to officials in Europe, the BA.4 and BA.5 subvariants will likely become the dominant strains of the virus in coming weeks, and those sublineages are already the dominant strains in South Africa, researchers told CNN.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

Global coronavirus cases cross 544.91 mln

WASHINGTON - The global COVID-19 case tally reached over 544.91 million with 6,746,636 deaths recorded to date, according to a Reuters tally on Saturday.The...

RPI gets $3.5M to develop COVID-19 antiviral drug

TROY, N.Y. (NEWS10) — Rensselaer Polytechnic Institute researchers have secured a five-year, $3.5 million grant to develop a low-dose, oral COVID antiviral drug that can be administered...

Related Articles

Global coronavirus cases cross 544.91 mln

WASHINGTON - The global COVID-19 case tally reached over 544.91 million with 6,746,636 deaths recorded to date, according to a Reuters tally on Saturday.The...

RPI gets $3.5M to develop COVID-19 antiviral drug

TROY, N.Y. (NEWS10) — Rensselaer Polytechnic Institute researchers have secured a five-year, $3.5 million grant to develop a low-dose, oral COVID antiviral drug that can be administered...